NOTCH1 and acute lymphoblastic leukemia: Notably, FB23‐2 treatment exhibited notable suppression of leukemic infiltration in the peripheral blood and in the extramedullary organs of Notch1‐induced T‐ALL mouse models but showed moderate inhibition in the bone marrow.